Meta-analysis of the association between functional MICA-TM polymorphisms and systemic lupus erythematosus, rheumatoid arthritis and ankylosing spondylitis

2014 ◽  
Vol 74 (2) ◽  
pp. 146-152 ◽  
Author(s):  
Y.H. Lee ◽  
S.-C. Bae ◽  
J.-H. Kim ◽  
G.G. Song
2021 ◽  
pp. 245-252
Author(s):  
David Howell

This chapter describes the anaesthetic management of the patient with those musculoskeletal disorders which are relevant to anaesthetic practice. Topics covered include rheumatoid arthritis, ankylosing spondylitis, systemic lupus erythematosus (SLE); systemic sclerosis; scoliosis and achondroplasia. For each topic, pre-operative investigation and optimisation, treatment, and anaesthetic management are described.


2020 ◽  
pp. 263-306
Author(s):  
Charlotte Frise ◽  
Sally Collins

This chapter covers rheumatic diseases in the pregnant patient. It gives background, clinical features, and management in the pregnant patient for rheumatoid arthritis, Sjögren’s syndrome, psoriatic arthritis, systemic lupus erythematosus, antiphospholipid syndrome, and ankylosing spondylitis among others. It also covers systemic sclerosis, osteoporosis, and other musculoskeletal problems. Medications and the use of biologics in pregnancy are also discussed, with reference to breastfeeding.


Author(s):  
Colin Berry

This chapter describes the anaesthetic management of the patient with those musculoskeletal disorders which are relevant to anaesthetic practice. Topics covered include rheumatoid arthritis, ankylosing spondylitis, systemic lupus erythematosus, systemic sclerosis, scoliosis, and achondroplasia. For each topic, preoperative investigation and optimization, treatment, and anaesthetic management are described.


Author(s):  
Lin Zhu ◽  
Peng Chen ◽  
Xuanjing Sun ◽  
Shuo Zhang

<b><i>Background:</i></b> Previous studies on polymorphisms in interleukin-1 (<i>IL-1</i>) and the risk of rheumatoid arthritis (RA)/systemic lupus erythematosus (SLE) yielded inconsistent results. <b><i>Objectives:</i></b> The authors performed this meta-analysis to more robustly evaluate associations between polymorphisms in the <i>IL-1</i> gene and the risk of RA/SLE. <b><i>Methods:</i></b> MEDLINE, Embase, Web of Science, Wanfang, VIP, and CNKI were systematically searched for eligible studies, and 34 relevant studies were finally selected to be eligible for inclusion. <b><i>Results:</i></b> We found that <i>IL-1A</i> +4845G/T polymorphism was significantly associated with the risk of RA in the overall population (dominant comparison: <i>p</i> = 0.02; overdominant comparison: <i>p</i> = 0.05; allele comparison: <i>p</i> = 0.04), whereas <i>IL-1B</i> +3954C/T polymorphism was significantly associated with the risk of RA in the overall population (overdominant comparison: <i>p</i> = 0.03; allele comparison: <i>p</i> = 0.01) and Asians (recessive comparison: <i>p</i> = 0.007; allele comparison: <i>p</i> = 0.002). In addition, we found that <i>IL-1A</i> –889C/T polymorphism was significantly associated with the risk of SLE in Caucasians (allele comparison: <i>p</i> = 0.04), <i>IL-1B</i> –31T/C polymorphism was significantly associated with the risk of SLE in the overall population (recessive comparison: <i>p</i> = 0.04), and <i>IL-1B</i> –511C/T polymorphism was significantly associated with the risk of SLE in Asians (recessive comparison: <i>p</i> = 0.01; allele comparison: <i>p</i> = 0.03). <b><i>Conclusions:</i></b> This meta-analysis suggests that <i>IL-1A</i> +4845G/T and <i>IL-1B</i> +3954C/T polymorphisms may influence the risk of RA, whereas <i>IL-1A</i> –889C/T, <i>IL-1B</i> –31T/C, and <i>IL-1B</i> –511C/T polymorphisms may influence the risk of SLE.


2015 ◽  
Vol 34 (10) ◽  
pp. 1713-1720 ◽  
Author(s):  
Qing Huang ◽  
Sha-Sha Tao ◽  
Yu-Jing Zhang ◽  
Chao Zhang ◽  
Lian-Ju Li ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document